Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 24, 2009

Premium

Aushon Biosystems has hired Mark Schmeizl to be vice president of North American sales. Schmeizl previously was a senior sales and marketing executive at PerkinElmer, Cisbio, and Affymetrix.


David Sneider has been named chief financial officer at Nerites. He joined the Madison, Wis.-based biotech from NimbleGen. He also previously served as CFO of Third Wave Technologies.


David Cox has joined Pfizer at chief scientific officer of its target generation unit. Cox was a co-founder of Perlegen, and he served as CSO at the company since 2000. He was a genetics and pediatrics professor at Stanford University School of Medicine, and he was a co-director of the Stanford Genome Center.


Joshua LaBaer has joined the Biodesign Institute at Arizona State University to serve as director of the new Virginia G. Piper Center for Personalized Diagnostics. LaBaer was most recently director of the Harvard Institute of Proteomics.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more